Literature DB >> 18248432

Production of biological active murine IFN-gamma by recombinant Lactococcus lactis.

Luis G Bermúdez-Humarán1, Naima G Cortes-Perez, René L'Haridon, Philippe Langella.   

Abstract

IFN-gamma is a cytokine produced primarily by both T lymphocytes and natural killer cells and it is considered to be an attractive therapeutic molecule. In the present study, a DNA sequence encoding the mature murine IFN-gamma (muIFN-gamma) protein was cloned and expressed in the food-grade lactic acid bacterium Lactococcus lactis. The activity of recombinant muIFN-gamma produced by genetically engineered L. lactis was confirmed in an antiviral assay using MoV cells infected with Vesicular Stomatitis Virus. The data provide the first demonstration that a Gram-positive bacterium, L. lactis, is able to produce functional muIFN-gamma. This recombinant strain could lead to the development of a new, well-tolerated vector to deliver active muIFN-gamma at the mucosal level.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18248432     DOI: 10.1111/j.1574-6968.2007.01038.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  6 in total

1.  Production of a particulate hepatitis C vaccine candidate by an engineered Lactococcus lactis strain.

Authors:  Natalie A Parlane; Katrin Grage; Jason W Lee; Bryce M Buddle; Michel Denis; Bernd H A Rehm
Journal:  Appl Environ Microbiol       Date:  2011-10-07       Impact factor: 4.792

2.  Directed chromosomal integration and expression of the reporter gene gusA3 in Lactobacillus acidophilus NCFM.

Authors:  Grace L Douglas; Todd R Klaenhammer
Journal:  Appl Environ Microbiol       Date:  2011-08-26       Impact factor: 4.792

3.  Chromosomal insertions in the Lactobacillus casei upp gene that are useful for vaccine expression.

Authors:  Bai-fen Song; Long-zhu Ju; Yi-jing Li; Li-jie Tang
Journal:  Appl Environ Microbiol       Date:  2014-03-21       Impact factor: 4.792

4.  Lactic Acid Bacteria: a promising alternative for recombinant protein production.

Authors:  Elena García-Fruitós
Journal:  Microb Cell Fact       Date:  2012-12-12       Impact factor: 5.328

5.  Oral Administration of Lactococcus lactis Producing Interferon Type II, Enhances the Immune Response Against Bacterial Pathogens in Rainbow Trout.

Authors:  Alvaro Santibañez; Diego Paine; Mick Parra; Carlos Muñoz; Natalia Valdes; Claudia Zapata; Rodrigo Vargas; Alex Gonzalez; Mario Tello
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

Review 6.  Lactococcus lactis As a Versatile Vehicle for Tolerogenic Immunotherapy.

Authors:  Dana P Cook; Conny Gysemans; Chantal Mathieu
Journal:  Front Immunol       Date:  2018-01-17       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.